Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Triangle Pharmaceuticals, Inc.
Durham, North Carolina, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Triangle Pharmaceuticals developed Coviracil (emtricitabine, FTC), which was near FDA approval at the time of acquisition by Gilead. Emtricitabine was later approved by the FDA in July 2003 for the treatment of HIV infection in combination with other antiretroviral agents.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Partnerships
Terrapin Technologies Inc.Warner-Lambert Co.
Beyond the preview
Go deeper on Triangle Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Triangle Pharmaceuticals, Inc..